Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.

BoNT was the treatment of choice for HFS due to its efficacy and safety profile. Further studies are needed to investigate the factors that influence the outcome, including the optimal timing of treatment, injection techniques, dosage, and the best selection criteria for formulations.